<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Bulaj G</submitter><pubmed_abstract>To improve long-term outcomes of therapies for chronic diseases, health promotion and lifestyle modifications are the most promising and sustainable strategies. In addition, advances in digital technologies provide new opportunities to address limitations of drug-based treatments, such as medication non-adherence, adverse effects, toxicity, drug resistance, drug shortages, affordability, and accessibility. Pharmaceutical drugs and biologics can be combined with digital health technologies, including mobile medical apps (digital therapeutics), which offer additional clinical benefits and cost-effectiveness. Promises of drug+digital combination therapies are recognized by pharmaceutical and digital health companies, opening opportunities for integrating pharmacotherapies with non-pharmacolog</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>612602</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8105510</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>From Precision Metapharmacology to Patient Empowerment: Delivery of Self-Care Practices for Epilepsy, Pain, Depression and Cancer Using Digital Health Technologies.</pubmed_title><pmcid>PMC8105510</pmcid><pubmed_authors>Clark J</pubmed_authors><pubmed_authors>Ebrahimi M</pubmed_authors><pubmed_authors>Bald E</pubmed_authors><pubmed_authors>Bulaj G</pubmed_authors></additional><is_claimable>false</is_claimable><name>From Precision Metapharmacology to Patient Empowerment: Delivery of Self-Care Practices for Epilepsy, Pain, Depression and Cancer Using Digital Health Technologies.</name><description>To improve long-term outcomes of therapies for chronic diseases, health promotion and lifestyle modifications are the most promising and sustainable strategies. In addition, advances in digital technologies provide new opportunities to address limitations of drug-based treatments, such as medication non-adherence, adverse effects, toxicity, drug resistance, drug shortages, affordability, and accessibility. Pharmaceutical drugs and biologics can be combined with digital health technologies, including mobile medical apps (digital therapeutics), which offer additional clinical benefits and cost-effectiveness. Promises of drug+digital combination therapies are recognized by pharmaceutical and digital health companies, opening opportunities for integrating pharmacotherapies with non-pharmacolog</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-05-29T22:24:53.159Z</modification><creation>2025-05-29T22:24:53.159Z</creation></dates><accession>S-EPMC8105510</accession><cross_references><pubmed>33972825</pubmed><doi>10.3389/fphar.2021.612602</doi></cross_references></HashMap>